Edition:
India

Arrowhead Pharmaceuticals Inc (ARWR.OQ)

ARWR.OQ on NASDAQ Stock Exchange Global Select Market

40.23USD
7 Aug 2020
Change (% chg)

$-0.79 (-1.93%)
Prev Close
$41.02
Open
$41.50
Day's High
$41.50
Day's Low
$39.60
Volume
355,353
Avg. Vol
440,310
52-wk High
$73.72
52-wk Low
$19.55

Select another date:

Fri, May 8 2020

BRIEF-Arrowhead Pharma Reports Quarterly Loss Per Share Of $0.20

* ARROWHEAD PHARMACEUTICALS REPORTS FISCAL 2020 SECOND QUARTER RESULTS

BRIEF-Arrowhead Pharmaceuticals Announces Retirement Of COO Bruce Given

* ARROWHEAD PHARMACEUTICALS ANNOUNCES RETIREMENT OF COO BRUCE GIVEN Source text for Eikon: Further company coverage:

BRIEF-Arrowhead Pharmaceuticals Files For Regulatory Clearance To Begin Phase 1/2A Study Of Aro-Enac For Treatment Of Cystic Fibrosis

* ARROWHEAD PHARMACEUTICALS FILES FOR REGULATORY CLEARANCE TO BEGIN PHASE 1/2A STUDY OF ARO-ENAC FOR TREATMENT OF CYSTIC FIBROSIS

BRIEF-Arrowhead Pharmaceuticals Announces Precautionary Measures To Mitigate Effects Of Coronavirus Spread

* ARROWHEAD PHARMACEUTICALS ANNOUNCES PRECAUTIONARY MEASURES TO MITIGATE EFFECTS OF NOVEL CORONAVIRUS (COVID-19) SPREAD

BRIEF-Arrowhead Pharmaceuticals Initiates Phase 1/2 Study Of ARO-HSD In Normal Healthy Volunteers And Patients With Nash Or Suspected Nash

* ARROWHEAD PHARMACEUTICALS INITIATES PHASE 1/2 STUDY OF ARO-HSD IN NORMAL HEALTHY VOLUNTEERS AND PATIENTS WITH NASH OR SUSPECTED NASH Source text for Eikon: Further company coverage:

Select another date: